Artificial intelligence is rapidly reshaping the life sciences industry, ushering in a new era of discovery, precision and efficiency. While the potential is enormous, so too is the responsibility that comes with deploying AI in a sector built on patient safety, ethical integrity and regulatory compliance.
KPMG’s Cian Kelliher, Consulting Partner, explores the importance of trust, data and governance in responsible AI adoption in life sciences - highlighting both the opportunities and the critical guardrails needed to implement AI safely and effectively.